Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

59.96 +0.95 (+1.61%)
Official Closing Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
48 49 Next >
How Medicare Advantage Insurers Will Be Affected By Proposed 2024 Payment Cut
Medicare Advantage insurers might see an average 2.27% reduction in baseline payments in 2024, the Centers for Medicare and Medicaid Services said Wednesday. 
Via Benzinga
Attorney Generals Of Several States Warn CVS, Walgreens Against Mailing Abortion Medication
Republican attorneys general in 20 states warned CVS Health Corp (NYSE: CVS) and Walgreens Boots Alliance Inc (NASDAQ: WBA) against mailing abortion pills in their jurisdictions. 
Via Benzinga
This Major Retailer Could Pose a Threat to Walgreens and CVS, and It's Not Walmart
Dollar General now has mobile health clinics available at a few of its locations. 
Via The Motley Fool
2 Top Dividend Growth Stocks to Buy in February
They don't offer the highest yields, but these strongly profitable businesses are poised to raise their payouts at a blistering pace. 
Via The Motley Fool
Why United Health, Humana And CVS Health Shares Are Moving Lower In Monday's After-Hours Session
Shares of several medicare insurers including UnitedHealth Group Inc (NYSE: UNH), Humana Inc (NYSE: HUM) and CVS Health Corp (NYSE: 
Via Benzinga
Here's How Much You Would Have Made Owning CVS Health Stock In The Last 20 Years
Via Benzinga
What 11 Analyst Ratings Have To Say About CVS Health
Via Benzinga
$100 Invested In CVS Health 20 Years Ago Would Be Worth This Much Today
Via Benzinga
eHealth Stock Rises from the Ashes. Time to Get In?
Online health insurance marketplace eHealth Inc. (NASDAQ: EHTH) stock has been on a rollercoaster ride since hitting its high of $152.19 in February 2020 
Via MarketBeat
Exposures COVID-19
3 Beaten-Down Blue Chip Stocks to Buy Right Now
These solid stocks are down but definitely not out. 
Via The Motley Fool
2 Solid Growth Stocks That Are Cheaper Than They Look
Both Alibaba and CVS should have better earnings numbers this year than last. 
Via The Motley Fool
Mergers and Acquisitions in 2023 Off To A Strong Start
Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road. 
Via MarketBeat
Exposures Product Safety
Better Stock to Buy in 2023: CVS Health or Walgreens Boots Alliance?
Here's how these two retail-pharmacy leaders stack up against each other. 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 22 companies hit new 52-week lows. 
Via Benzinga
Is Amazon the Future of Healthcare?
The e-commerce titan announced the RxPass subscription for Prime members. What companies will this service disrupt, and can Amazon stock benefit? 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday, 17 stocks hit new 52-week lows. 
Via Benzinga
CVS Health is Growing into an Integrated Healthcare Organization
Pharmacy, insurance, and healthcare services provider CVS Health Corporation (NYSE: CVS) shares are trading near 52-week lows despite the recent rally in the 
Via MarketBeat
Exposures COVID-19
Constructing A Dividend Growth Stock Portfolio For Total Return
A common mistake that investors make regarding dividend portfolio construction is not having a well-thought-out plan. 
Via Talk Markets
Rite Aid Starts Selling Abortion Medication From Few Pharmacies: Report
Rite Aid Corp (NYSE: RAD) plans to dispense abortion pill mifepristone in a limited number of its pharmacies and will serve customers in person or through mail delivery. 
Via Benzinga
Is This Hot Dividend Stock a Buy for Growth Investors?
This health insurer is a world-class business. But does that make the stock a savvy buy? 
Via The Motley Fool
3 Dividend Stocks Trading Near Their 52-Week Lows
Income investors looking to buy on a pullback might be interested in these stocks. 
Via The Motley Fool
Is Walgreens Boots Alliance Earnings Miss Good For Investors?
Integrated healthcare and pharmacy retailer Walgreens Boots Alliance Inc. (NYSE: WBA) stock recovered some sell-off losses from its fiscal Q1 2023 earnings 
Via MarketBeat
Topics Earnings Lawsuit
Exposures COVID-19 Financial Legal
Time To Buy CVS Or Oak Street Health Stock On Potential Acquisition?
News of CVS Health potentially acquiring Oak Street Health for $10 billion broke this week and highlighted what could be another large acquisition in 2023. For Oak Street Health, the possibility of... 
Via Talk Markets
The Viral “Tripledemic” Opportunity
Between Covid, the flu, and RSV, investors in over-the-counter consumer pharmaceutical companies might be wondering if now is a logical time to up their holdings in the companies that make cold and flu... 
Via Talk Markets
Take Warren Buffett's Advice and Do This During the Bear Market
Buffett isn't concerned when stock prices fall. 
Via The Motley Fool
Why Disney, Boeing And CVS Are This Investor's Top Stocks For 2023
Sand Hill Global Advisors' Brenda Vingiello laid out her top stocks for 2023 Wednesday afternoon on CNBC's "Fast Money Halftime Report." Here's a look at her three best ideas for 
Via Benzinga
Can CVS Save Oak Street Health (OSH) Stock?
Oak Street Health (OSH) stock is a hot topic among traders on Tuesday following reports that CVS (CVS) intends to acquire the company. 
Via InvestorPlace
Stock Indexes Move Lower Ahead of Key Consumer Data, More Fed Speakers
(Tuesday Market Open) Investors remained subdued Tuesday morning after a reality check from Federal Reserve speakers yesterday and rising anticipation ahead of a key U.S. inflation measure. 
Via Benzinga
Stocks Sluggish After Fed Chair Comments
Wall Street is struggling for direction today, with all three major indexes trading on both sides of the aisle. 
Via Talk Markets
Jim Cramer Says Forget AT&T, This 'Class Of The Field' Communications Stock Is Better
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary. 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.